Page 158 - 南京医科大学学报自然科学版
P. 158

第41卷第6期
               ·936 ·                            南 京    医 科 大 学 学         报                        2021年6月


                  disorder of patients with endometriosis[J]. Reprod Sci,  Mol Hum Reprod,2018,24(7):357-365
                  2019,26(8):1130-1138                          [25] PAN C,STEVIC I,MÜLLER V,et al. Exosomal microR⁃
             [21] ZENG Z,WANG K,LI Y,et al. Down⁃regulation of mi⁃   NAs as tumor markers in epithelial ovarian cancer[J].
                   croRNA ⁃ 451a facilitates the activation and proliferation  Mol Oncol,2018,12(11):1935-1948
                   of CD4(+)T cells by targeting Myc in patients with dilat⁃  [26] KIM S,CHOI M C,JY J,et al. Serum exosomal miRNA⁃
                   ed cardiomyopathy[J]. J Biol Chem,2017,292(14):   145 and miRNA⁃200c as promising biomarkers for preop⁃

                   6004-6013                                         erative diagnosis of ovarian carcinomas[J]. J Cancer,
             [22] ZHANG L,LI H,YUAN M,et al. Serum exosomal MicroR⁃  2019,10(9):1958-1967
                   NAs as potential circulating biomarkers for endometriosis  [27] ZHOU J R,LI X D,WU X L,et al. Exosomes released
                  [J]. Dis Markers,2020,2020:2456340                 from Tumor ⁃ Associated macrophages transfer miRNAs
             [23] GIUDICE L C,KAO L C. Endometriosis[J]. Lancet,     that induce a Treg/Th17 cell imbalance in epithelial ovari⁃

                   2004,364(9447):1789-1799                          an cancer[J]. Cancer Immunol Res,2018,6(12):1578-
             [24] WU D,LU P,MI X,et al. Exosomal miR⁃214 from endo⁃  1592
                   metrial stromal cells inhibits endometriosis fibrosis[J].              [收稿日期] 2020-09-10






              






             (上接第926页)                                               nasopharyngeal carcinoma patients treated with endoscop⁃
                   sults of the KEYNOTE⁃028 study[J]. J Clin Oncol,2017,  ic nasopharyngectomy:a meta⁃analysis[J]. Int Forum Al⁃
                   35(36):4050-4056                                  lergy Rhinol,2020,10(8):1001-1011
             [30] MA B,LIM W T,GOH B C,et al. Antitumor activity of  [34] WONG E,LIEW Y T,LOONG S P,et al. Five⁃year surviv⁃
                   nivolumab in recurrent and metastatic nasopharyngeal car⁃  al data on the role of endoscopic endonasal nasopharyn⁃
                   cinoma:an international,multicenter study of the Mayo  gectomy in advanced recurrent rT3 and rT4 nasopharyn⁃
                   clinic phase 2 consortium(NCI⁃9742)[J]. J Clin Oncol,  geal carcinoma[J]. Ann Otol Rhinol Laryngol,2020,129
                   2018,36(14):1412-1418                            (3):287-293
             [31] LV J W,JY L,LUO L N,et al. Comparative safety and ef⁃  [35] LIU Y P,LV X,ZOU X,et al. Minimally invasive surgery
                   ficacy of anti ⁃ PD ⁃ 1 monotherapy,chemotherapy alone,  alone compared with intensity⁃modulated radiotherapy for
                   and their combination therapy in advanced nasopharyn⁃  primary stage Ⅰ nasopharyngeal carcinoma[J]. Cancer
                   geal carcinoma:findings from recent advances in land⁃  Commun(Lond),2019,39(1):75
                   mark trials[J]. J Immunother Cancer,2019,7(1):159  [36] WENG J J,JZ W,LI M,et al. Effects of surgery combined
             [32] 王剑祁,韩     日,李湘平,等. 复发NPC挽救性手术有效                    with chemoradiotherapy on short⁃ and long⁃term outcomes
                   性与安全性的Meta分析[J]. 中华耳鼻咽喉头颈外科杂                      of early⁃stage nasopharyngeal carcinoma[J]. Cancer Man⁃
                   志,2019,54(9):676-684                              ag Res,2020,12(202012):7813-7826
             [33] YANG J,SONG X,SUN X,et al. Outcomes of recurrent                        [收稿日期] 2020-12-02
   153   154   155   156   157   158   159   160